Recruiting NA Mild Traumatic Brain Injury

New treatment option for Mild Traumatic Brain Injury

Official title Facilitating Access to Specialty Treatment

ClinicalTrials.gov ID: NCT05741411

What this study is testing

What it's testing
The goal of this hybrid implementation-effectiveness study is to evaluate the effectiveness (hastened recovery times) and feasibility (fidelity in connecting to concussion specialty care) of a novel mobile health intervention, designed to reduce disparities in access to specialty care through the use of remote patient monitoring (RPM) to facilitate care hand-off from the emergency department (ED) to concussion specialty care. Participants will report their symptoms and activity once daily through RPM chat technology that is linked to their electronic health record and prompts referral to specialty care.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 13 to 18

You may be able to join if

  • for concussed people:
  • Males and females age 13 - 18
  • Present to the Children's Hospital of Philadelphia (CHOP) Emergency Department (ED) within 72 hours of head injury
  • Meet criteria for concussion as defined by the most recent International Consensus Statement on Concussion
  • Own a smartphone

You likely can't join if

  • for concussed people:
  • Glasgow Coma Scale score \<13
  • Lower extremity trauma
  • A prior concussion within 1 month
  • Non-English speaking
  • Admission to the hospital at the initial head injury visit
See the full eligibility criteria
Who can join
  • for concussed people:
  • Males and females age 13 - 18
  • Present to the Children's Hospital of Philadelphia (CHOP) Emergency Department (ED) within 72 hours of head injury
  • Meet criteria for concussion as defined by the most recent International Consensus Statement on Concussion
  • Own a smartphone
  • Meet criteria for moderate-to-high risk for Persistent Post-Concussion Symptoms according to 5P rule (score \>3/12)
What rules you out
  • for concussed people:
  • Glasgow Coma Scale score \<13
  • Lower extremity trauma
  • A prior concussion within 1 month
  • Non-English speaking
  • Admission to the hospital at the initial head injury visit
  • Previously enrolled in the study
  • Inability to complete study procedures. Inclusion Criteria for parents:
  • Child meets the study eligibility criteria Exclusion Criteria for parents:
  • Non-English speaking Inclusion Criteria for providers:
  • ED or specialty provider caring for at least one patient via the mobile Health (mHealth)-facilitated care handoff strategy Exclusion Criteria for providers:
  • Non-English speaking

The study team makes the final eligibility decision.

Where it's taking place

  • Philadelphia, Pennsylvania, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 13 years to 18 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.